[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334592-105":59,"doc-detail-334592-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-prognostic-utility-of-temporalis-muscle-thickness-measured-on-magnetic-resonance-scans-in-patients-with-intra-axial-malignant-brain-tumours-a-systematic-review-and-meta-analysis","The prognostic utility of temporalis muscle thickness measured on magnetic resonance scans in patients with intra-axial malignant brain tumours - A systematic review and meta-analysis","","Sarcopenia is linked to poorer outcomes in solid cancers, motivating interest in temporalis muscle thickness (TMT) as an objective surrogate. This systematic review and meta-analysis evaluates TMT measured on magnetic resonance scans against outcome measures in patients with malignant intra-axial neoplasms. Searches of Medline, Embase, Scopus, and Cochrane were analyzed with RevMan 5.4, while vote counting applied when meta-analysis was not feasible, using GRADE to assess evidence certainty.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-prognostic-utility-of-temporalis-muscle-thickness-measured-on-magnetic-resonance-scans-in-patients-with-intra-axial-malignant-brain-tumours-a-systematic-review-and-meta-analysis/334592/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-prognostic-utility-of-temporalis-muscle-thickness-measured-on-magnetic-resonance-scans-in-patients-with-intra-axial-malignant-brain-tumours-a-systematic-review-and-meta-analysis/334592.png","ImageObject",300,407,{"name":92,"@type":93},"Anda","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of measuring temporalis muscle thickness (TMT) in malignant intra-axial tumours?","Question",{"text":112,"@type":113},"The study aims to evaluate the relationship between TMT and outcome measures in patients with malignant intra-axial neoplasms, using TMT as a marker of sarcopenia.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were outcomes analyzed in this systematic review?",{"text":117,"@type":113},"The review searched Medline, Embase, Scopus, and Cochrane. Event ratios with 95% confidence intervals were analyzed using RevMan 5.4, and where meta-analysis was not possible, vote counting was used; GRADE determined evidence certainty.",{"name":119,"@type":110,"acceptedAnswer":120},"What prognostic associations were found for glioblastoma, brain metastases, and primary CNS lymphoma?",{"text":121,"@type":113},"Thicker TMT was protective for overall survival and progression free survival in glioblastoma, and protective for both overall and progression free survival in primary CNS lymphoma. For brain metastases, thicker TMT showed protection for overall survival but no association with progression free survival.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334592,1790013869,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","World Neurosurgery: X 22 (2024) 100318  \nContents lists available at ScienceDirect  \nWorld Neurosurgery: X  \njournal [homepage:](homepage: www.journals.elsevier.com/world-neurosurgery-x)[ www.journals.elsevier.com/world-neurosurgery-x](homepage: www.journals.elsevier.com/world-neurosurgery-x)  \n| The prognostic utility of temporalis muscle thickness measured on magnetic resonance scans in patients with intra-axial malignant brain tumours: A systematic review and meta-analysis |  |  | |\n| --- | --- | --- | --- |\n| Olatomiwa Olukoyaa, b, *, \\#, Temidayo Osunronbia, c, \\#, Damilola A. Jesuyajolua, Blossom\u003Cbr>C. Uwagaa, Ayomide Vaughan a, Oluwabusayo Alukoa, Temitayo O. Ayantayo a, Jeremiah O.\u003Cbr>I. Daniela, Samuel O. Davida, Habiblah A. Jagunmolua, Alieu Kanua, Ayomide T. Kayode a, Tobi\u003Cbr>N. Olajidea, Lewis Thorne b\u003Cbr>a Neurosurgery Department, Surgery Interest Group of Africa, Lagos, Nigeria\u003Cbr>b The National Hospital for Neurology and Neurosurgery, London, United Kingdom\u003Cbr>c Department of Neurosurgery, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom |  |  |  |\n| A R T I C L E I N F O |  | A B S T R A C T |  |\n| Keywords:\u003Cbr>Brain metastases\u003Cbr>Glioblastoma (GBM)\u003Cbr>Primary CNS lymphoma Prognosis\u003Cbr>Sarcopenia\u003Cbr>Temporalis muscle thickness (TMT) |  | Introduction: Sarcopenia is associated with worsened outcomes in solid cancers. Temporalis muscle thickness (TMT) has emerged as a measure of sarcopenia. Hence, this study aims to evaluate the relationship between TMT and outcome measures in patients with malignant intra-axial neoplasms.\u003Cbr>Method: We searched Medline, Embase, Scopus and Cochrane databases for relevant studies. Event ratios with 95% confidence intervals (CI) were analysed using the RevMan 5.4 software. Where meta-analysis was impossible, vote counting was used to determine the effect of TMT on outcomes. The GRADE framework was used to determine the certainty of the evidence.\u003Cbr>Results: Four outcomes were reported for three conditions across 17 studies involving 4430 patients. Glioblastoma: thicker TMT was protective for overall survival (OS) (HR 0.59; 95% CI 0.46–0.76) (GRADE low), progression free survival (PFS) (HR 0.40; 95% CI 0.26–0.62) (GRADE high), and early discontinuation of treatment (OR 0.408; 95% CI 0.168–0.989) (GRADE high); no association with complications (HR 0.82; 95% CI 0.60–1.10)(GRADE low). Brain Metastases: thicker TMT was protective for OS (HR 0.73; 95% CI 0.67–0.78) (GRADE moderate); no association with PFS (GRADE low). Primary CNS Lymphoma: TMT was protective for overall survival (HR 0.34; 95% CI 0.19–0.60) (GRADE moderate) and progression free survival (HR 0.23; 95% CI 0.09–0.56) (GRADE high).\u003Cbr>Conclusion: TMT has significant prognostic potential in intra-axial malignant neoplasms, showing a moderate to high certainty for its association with outcomes following GRADE evaluation. This will enable shared decision making between patients and clinicians. |  |\n\n1. Introduction  \nIntra-axial tumours account for more than 75% of intracranial tumours, representing a significant burden of disease.1 The most common primary central nervous system (CNS) tumour in adults is glioblastoma which is an aggressive tumour with a median survival time of 15-months and a 5-year survival of \u003C5% following diagnosis, with outcomes that are influenced by the patient’s age and performance status.2 Brain  \nmetastases are in fact the most common central nervous system neoplasms seen in 10–40% of patients with systemic cancer. Despite advances in the treatment of systemic cancers, the prognosis for patients with cerebral metastases is poor. Surgical resection improves survival but only in selected patients: those with a limited burden of surgically accessible intracranial disease, good performance status and overall prognosis.3 Primary central nervous system (CNS) lymphoma (PCNSL), in contrast, only represents 3–4% of all brain tumours and despite advances in","cbCaio8geepNJrlf","https://ap.wps.com/l/cbCaio8geepNJrlf","pdf",6370424,"English","# Introduction\n# Abbreviations\n# Abstract","[{\"question\":\"What is the purpose of measuring temporalis muscle thickness (TMT) in malignant intra-axial tumours?\",\"answer\":\"The study aims to evaluate the relationship between TMT and outcome measures in patients with malignant intra-axial neoplasms, using TMT as a marker of sarcopenia.\"},{\"question\":\"How were outcomes analyzed in this systematic review?\",\"answer\":\"The review searched Medline, Embase, Scopus, and Cochrane. Event ratios with 95% confidence intervals were analyzed using RevMan 5.4, and where meta-analysis was not possible, vote counting was used; GRADE determined evidence certainty.\"},{\"question\":\"What prognostic associations were found for glioblastoma, brain metastases, and primary CNS lymphoma?\",\"answer\":\"Thicker TMT was protective for overall survival and progression free survival in glioblastoma, and protective for both overall and progression free survival in primary CNS lymphoma. For brain metastases, thicker TMT showed protection for overall survival but no association with progression free survival.\"}]","The prognostic utility of temporalis muscle thickness measured on magnetic resonance scans in patients with intra-axial malignant brain tumours - A systematic review and meta-analysis | PDF",1790007402,25]